Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CStone Pharmaceuticals Initiates Two Pivotal Phase II Studies of the Anti-PD-L1 Monoclonal Antibody CS1001 2018-06-13 15:09
Dr. Ming Liu joins ChemPartner as Vice President and Head of Biology and Pharmacology 2018-06-12 23:00
China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant 2018-06-11 20:00
OliX Pharmaceuticals receives Clinical Trial Authorization in the UK to initiate Phase I study with OLX10010, an anti-scar RNAi therapeutics 2018-05-29 16:01
Commencement of BNC210 Phase 2 Clinical Trial for the Treatment of Agitation 2018-05-24 21:00
Samsung BioLogics Receives an additional FDA Approval for its world largest Plant's Production 2018-05-24 12:05
EmeTerm Anti-Nausea and Vomiting Wristband is FDA Cleared 2018-05-21 21:00
GC Pharma to Establish Curevo - a Seattle-based New Company Dedicated to Development of New Vaccines 2018-05-21 07:00
WuXi Biologics to Build an Integrated Biologics Development, Clinical and Commercial Manufacturing Center in Shijiazhuang 2018-05-16 18:09
CStone announces first patient dosing with anti-PD-1 antibody CS1003 in Phase I study in Australia 2018-05-14 18:36
NeuClone Announces Preclinical Results for Stelara® (ustekinumab) Biosimilar Candidate 2018-05-10 20:00
China Biologic Reports Financial Results for the First Quarter of 2018 2018-05-05 04:30
CStone announces first patient dosed with anti-CTLA-4 antibody CS1002 of a Phase I study in Australia 2018-05-04 14:47
OnKure Close $7M Series A Financing to Support Development of Epigenetics Drug 2018-05-02 23:00
Sinovac Temporarily Blocks Access to Its Websites 2018-04-30 21:00
GC Pharma Reports Q1 2018 Results 2018-04-27 16:10
WuXi STA Announces to Build a New R&D Center in Shanghai 2018-04-27 08:00
Innovent Biologics completed US$150 million Series E round financing 2018-04-26 20:47
Samsung BioLogics becomes the first in the South Korean pharma industry to achieve ISO 22301 Certificate 2018-04-25 16:09
China Biologic to Report First Quarter of 2018 Financial Results 2018-04-24 20:00
1 133 134 135 136 137 158